AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling

References

Page 1

	Year	Citations
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults Eugenia E. Calle, Carmen Rodríguez, Kimberly A Walker-Thurmond, New England Journal of Medicine	2003	7.7K
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 David A. Barbie, Pablo Tamayo, Jesse S. Boehm, Nature Systems BiologyOncogenic AgentMedicineKras-driven CancersCancer Biology	2009	4.1K
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses Siân Jones, D. Williams Parsons, Jimmy Lin, Science EngineeringGeneticsPathologyCancer BiologyTumor Biology	2008	4K
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Heather R. Christofk, Matthew G. Vander Heiden, Marian H. Harris, Nature Tumor BiologyMedicineMolecular BiologyPyruvate KinaseProtein Phosphorylation	2008	2.8K
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras Marcus Kretzschmar, Jacqueline Doody, Inna Timokhina, Genes & Development	1999	997
A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival Anurag Singh, Patricia Greninger, Daniel R. Rhodes, Cancer Cell Tumor BiologyTranscriptional RegulationSignal TransductionSignaling PathwayCell Regulation	2009	855
Physical Activity, Obesity, Height, and the Risk of Pancreatic Cancer Dominique S. Michaud JAMA	2001	664
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway Zhiwei Wang, Yiwei Li, Dejuan Kong, Cancer Research	2009	618
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon Kevin M. Haigis, K Kendall, Yufang Wang, Nature Genetics Differential EffectsOncogenic AgentMedicineTumor ProgressionColorectal Cancer	2008	587
Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival Helmut Friess, Yoichiro Yamanaka, Markus W. Büchler, Gastroenterology Pancreatic CancerMedicinePathologyEnhanced ExpressionCancer Biology	1993	518

Page 1